Advanced searches left 3/3

Cardiogenic - Europe PMC

Summarized by Plex Scholar
Last Updated: 10 September 2022

* If you want to update the article please login/register

Cardiogenic shock due to yew poisoning rescued by VA-ECMO: case report and literature review.

Ingestion of leaves of the European yew tree can cause fatal cardiac arrestrhythmias and acute cardiogenic shock. Intoxication as reversible causes of cardiac arrest in this study, this book emphasizes the importance of intoxication as reversible causes of cardiac arrest, as well as increasing evidence to the body of existing literature, recommending the use of venoarterial extracorporeal membrane oxygenation in patients with yew poisoning and cardiogenic shock.

Source link: https://europepmc.org/article/MED/35942511


Incidence and outcomes of cardiogenic shock among women with spontaneous coronary artery dissection.

We estimated the incidence of CS among women with and without SCAD, and odds for obtaining CS after adjusting for baseline characteristics. Patients with SCAD were younger and had fewer comorbidities, but they had a higher risk of CS than patients without SCAD, and they were still at an elevated risk after accounting for baseline comorbidities. Patients with CS had lower in-hospital mortality than non-SCAD, and were more likely to receive mechanical circulatory assistance. Conclusions In a nationally representative sample of women admitted to AMI, we discovered that patients with SCAD were at a greater risk of developing CS and required more frequent use of mechanical circulatory services, but women with SCAD had a higher risk of experiencing AEMI from causes other than SCAD.

Source link: https://europepmc.org/article/MED/36073664


Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19.

During the coronavirus disease 2019 pandemic, the aim was to determine the characteristics and outcomes of patients with acute myocardial infarction and cardiogenic shock. Background The COVID-19 pandemic has caused complications in providing acute cardiovascular care. Patients presenting with AMICS during COVID-19 in the United States have not been well defined, and quality monitoring and outcomes of patients have not been well defined. Methods We discovered 406 patients from the National Cardiogenic Shock Initiative with AMICS and divided them into those presenting before and those presenting during the COVID-19 pandemic. Patients presenting during the pandemic were less likely to be black than those who were not there before. During the COVID-19 period, patients with ST-elevation myocardial infarction became more frequent. Patients presenting with AMICS have remained highly mobile among hospitals in the NCSI during the COVID-19 pandemic.

Source link: https://europepmc.org/article/MED/36073018


Mechanical Circulatory Support Devices for the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction-A Review.

An acute myocardial infarction complicating acute myocardial infarction is a difficult medical condition associated with poor prognosis. This article explores the latest developments in the aftermath of acute myocardial infarction, as well as the common challenges that accompany this procedure.

Source link: https://europepmc.org/article/MED/36079170


Right Heart Catheterization Timing and Outcomes of Cardiogenic Shock: Analysis from the National Readmission Database.

Introduction Physiological Study In cardiogenic, right heart catheterization use in cardiogenic showed significant mortality benefit, according to recent studies. Because of a lack of available data, the optimal timing of RHC in those patients is uncertain. Patients with cardiac arrest or with a history of ventricular assist systems or heart transplantation were refused admission to the hospital. RHC timing in the index admission and hospital outcomes was determined by multivariable logistic, cox, and linear regression models, with all-cause 30-day readmissions used. RHC was more likely to occur in large teaching hospitals than in large teaching hospitals. Patients in the early RHC group had a lower incidence of AKI, a higher risk of MCS use, shorter LOS, lower hospital charges, and lower readmission rates relative to the late RHC group. Despite increased mortality, the subgroup analysis of patients who did not receive MCS during the index admission showed similar results, even though with increased mortality.

Source link: https://europepmc.org/article/MED/36058343


Clinical Outcomes and Cost Associated With an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump in Patients Presenting With Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Importance Intravascular microaxial left ventricular assist device, compared to the intra-aortic balloon pump, has been associated with an increased risk of death and bleeding among patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention. However, there are some studies comparing device therapy with a broader range of health outcomes, including findings on long-term outcomes and cost, but data on long-term outcomes and cost is limited. AMI that is difficult by CS is a chronic disease that is interconnected with intravascular LVAD or IABP use, clinical outcomes, and costs in patients with AMI complicated by CS. Participants from 14 states around the United States were enrolled in this retrospective cohort study, which used administrative claims information for commercially insured patients. Conclusions and value In this propensity-matched review of patients undergoing PCI for AMI complicating by CS, intravascular LVAD use was correlated with increased risk of mortality, bleeding, KRT, and cost in comparison to IABP.

Source link: https://europepmc.org/article/MED/35849410


Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis.

Background In ST-elevation's heart infarction, percutaneous coronary intervention is associated with less bleeding and mortality than transfemoral access. Patients in cardiogenic shock are less likely to be treated with TFA. In CS, the aim of this meta-analysis is to determine the safety and effectiveness of TRA vs. TFA. Conclusions: TRA is a major cause of reduced mortality and bleeding difficulties in PCI with CS, especially in TFA, who has similar TIMI3 flow and procedural success rates as TFA.

Source link: https://europepmc.org/article/MED/35460230


Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis.

The incidence of a patient with a refractory cardiogenic shock on venoarterial extracorporeal membrane oxygenation remains high, and hyperoxia may exacerbate this prognosis. Adult patients who were hospitalized for refractory cardiogenic shock were included in the study. Following admission, the absolute peak PaO 2, the average daily peak PaO 2, the overall mean PaO 2, and the occurrence of hyperoxia were recorded. Non-survivors' mean daily peak, absolute peak, and overall mean PaO 2 values were much higher in non-survivors than in survivors. The mean daily peak PaO 2, absolute peak PaO 2, and overall mean PaO 2 were independent predictors of 28-day mortality in a multivariate logistic regression study. Conclusions High oxygen levels were associated with 28-day deaths in patients on VA-ECMO treatment for refractory cardiogenic shock.

Source link: https://europepmc.org/article/MED/36028883


Hospital characteristics are associated with clinical outcomes in patients with cardiogenic shock.

The impact of receiving hospital information in emergency medical services treated cardiogenic shock is unclear. Methods This population-based cohort study in Victoria, Australia, found that consecutive adult patients with cardiogenic shock who were transferred to hospital by emergency medical services between 1 January 2015 and 30 June 2019. Compared to non-cardiac centers, EMS transport to a cardiac center was associated with significantly reduced 30-day mortality rates for a 30-day mortality center. Hospitals in the highest volume quartile had a reduced risk of 30-day mortality compared to the lowest annual cardiogenic shock volume quartile. A stepwise decrease in the adjusted likelihood of 30-day mortality was observed in patients transferred by EMS to trauma level 1 centers, compared to cardiothoracic surgical centers, non-cardiac surgical metropolitan, and rural cardiac centers, all p 0. 05. Conclusion In patients with cardiogenic shock, receiving hospital services are related to survival rates.

Source link: https://europepmc.org/article/MED/36018300

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions